​

OnKure Therapeutics Ownership | Who Owns OnKure Therapeutics?

OverviewFinancialsChart

OnKure Therapeutics Ownership Summary

OnKure Therapeutics is owned by 47.32% institutional investors, 1.79% insiders, and 50.89% retail investors. Acorn capital advisors is the largest institutional shareholder, holding 21.02% of OKUR shares.

OKUR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOnKure Therapeutics47.32%1.79%50.89%
SectorHealthcare Stocks 232.12%10.72%-142.83%
IndustryBiotech Stocks 383.51%10.54%-294.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Acorn capital advisors2.84M21.02%$7.81M
Shay capital917.93K6.79%$2.52M
Prosight management, lp816.91K6.05%$2.37M
Rosalind advisors730.49K5.41%$2.12M
Vestal point capital, lp635.00K4.70%$1.75M
Vanguard group626.59K4.64%$1.82M
Highbridge capital management542.36K4.01%$1.57M
Stepstone group lp491.94K3.64%$1.35M
Cantor fitzgerald, l. p.491.86K3.64%$1.35M
Nea management company478.55K3.54%$1.32M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Acorn capital advisors2.84M3.96%$7.81M
Rosalind advisors730.49K0.74%$2.12M
Stepstone group lp491.94K0.64%$1.35M
Prosight management, lp816.91K0.49%$2.37M
Rangeley capital155.49K0.37%$427.60K
Shay capital917.93K0.22%$2.52M
Aldebaran capital41.28K0.11%$119.72K
Vestal point capital, lp635.00K0.08%$1.75M
Nea management company478.55K0.07%$1.32M
Aisling capital management lp88.61K0.05%$256.96K

Top Buyers

HolderShares% AssetsChange
Rosalind advisors730.49K0.74%730.49K
Prosight management, lp816.91K0.49%548.95K
Shay capital917.93K0.22%135.89K
Rangeley capital155.49K0.37%125.59K
Renaissance247.35K0.00%71.60K

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp---1.84M
Perceptive advisors---1.00M
Samsara biocapital---824.15K
Blackrock funding, inc. /de52.68K--512.16K
Affinity asset advisors---347.99K

New Positions

HolderShares% AssetsChangeValue
Rosalind advisors730.49K0.74%730.49K$2.12M
Jane street group19.41K-19.41K$56.30K
Fmr50.00-50.00$138.00
Northwestern mutual wealth management2.00-2.00$6.00

Sold Out

HolderChange
Mai capital management-6.00
Gf fund management-271.00
Mirae asset global investments-497.00
China universal asset management-2.25K
Adar1 capital management-10.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202526-38.10%6,391,960-37.45%470.83%12-29.41%10-16.67%
Sep 30, 202542-8.70%10,219,6085.81%751.48%17-19.05%12-7.69%
Jun 30, 2025484.35%10,776,588-9.78%791.01%23-50.00%13-
Mar 31, 20252-710,559-5-2---

Recent Insider Transactions

DateNameRoleActivityValue
Dec 22, 2025Saccomano Nicholas A President and CEOSell$258.19
Dec 22, 2025Leverone Jason A. Chief Financial OfficerSell$896.25
Sep 22, 2025Saccomano Nicholas A President and CEOSell$230.87
Sep 22, 2025Leverone Jason A. Chief Financial OfficerSell$794.92
Jun 23, 2025Saccomano Nicholas A President and CEOSell$209.81

Insider Transactions Trends

DateBuySell
2025 Q4-2
2025 Q3-2
2025 Q228
2025 Q1--
2024 Q4--

OKUR Ownership FAQ

Who Owns OnKure Therapeutics?

OnKure Therapeutics shareholders are primarily institutional investors at 47.32%, followed by 1.79% insiders and 50.89% retail investors. The average institutional ownership in OnKure Therapeutics's industry, Biotech Stocks , is 383.51%, which OnKure Therapeutics falls below.

Who owns the most shares of OnKure Therapeutics?

OnKure Therapeutics’s largest shareholders are Acorn capital advisors (2.84M shares, 21.02%), Shay capital (917.93K shares, 6.79%), and Prosight management, lp (816.91K shares, 6.05%). Together, they hold 33.86% of OnKure Therapeutics’s total shares outstanding.

Does Blackrock own OnKure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of OnKure Therapeutics.

Who is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.96% of its assets in 2.84M OnKure Therapeutics shares, valued at 7.81M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools